VEGFA and retinopathy of prematurity: In their prospective randomized trial comparing intravitreal bevacizumab with conventional laser photocoagulation therapy, Mintz-Hittner et al. reported on behalf of the BEAT-ROP Cooperative Group a significant benefit of anti-VEGF in the treatment of stage 3+ zone 1 disease [80].